
Peptides and Proteins
Found 3153 products of "Peptides and Proteins"
Semaglutide Impurity 54 (D-Ala 18)
D-Ala(18)-Semaglutide is a semaglutide impurity. The amino acid at position 18 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/molDes-Glu(3)-Semaglutide
Des-Glu(3)-semaglutide is a semaglutide-related impurity. This des-amino acid form has got the glutamic acid or glutamate (Glu) amino acid from position 3 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.Formula:C182H284N44O56Molecular weight:3,984.53 g/molD-Ser(11)-Semaglutide
D-Ser(11)-Semaglutide is a semaglutide impurity. The amino acid at position 11 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/molD-Ala(24)-Semaglutide
D-Ala(24)-Semaglutide is a semaglutide impurity. The amino acid at position 24 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/molD-His(1)-Semaglutide
D-His(1)-Semaglutide is a semaglutide impurity. The amino acid at position 1 has been replaced by the D-form of the amino acid D-histidine (D-His). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/molSemaglutide Impurity 56 (D-Glu 21)
D-Glu(21)-Semaglutide is a semaglutide impurity. The amino acid at position 21 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/molD-Ala-(19)-Semaglutide
D-Ala(19)-Semaglutide is a semaglutide impurity. The amino acid at position 19 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/mol(S,E)-N-(1-(3-Methylbut-1-enylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
CAS:R-N-(1-(3-methylbut-1-enyl)-1-oxo-3-phenylpropan-2-yl) pyrazine-2-carboxamide is a drug product that is used for the treatment of bacterial infections. The compound is an impurity in the synthesis of other compounds and is also used as an analytical standard. It is synthesized from commercially available starting materials and through custom synthesis. R-N-(1-(3-methylbut-1-enyl)-1--oxo--3--phenylpropan--2--yl)pyrazine--2--carboxamide has been shown to be metabolized by CYP450 enzymes, which are responsible for the metabolism of many drugs. R-(1-(3Methylbut 1Enylamino)-1Oxo 3Phenylpropan 2Yl)Pyrazine 2Carboxamide has not been evaluated as a drug product and therefore does notFormula:C19H22N4O2Purity:Min. 95%Molecular weight:338.4 g/molSemaglutide Impurity 60 (D-Arg 30)
D-Arg(30)-Semaglutide is a semaglutide impurity. The amino acid at position 30 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/mol3,3',5,5'-Tetraiodothyroformic acid
CAS:Cymit Quimicaetic beta-D-glucosiduronic acidFormula:C13H6I4O4Purity:Min. 95 Area-%Color and Shape:Off-White PowderMolecular weight:733.8 g/molSemaglutide Impurity 101 (D-Glu 3)
D-Glu(3)-Semaglutide is a semaglutide impurity. The amino acid at position 3 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/mol(R)-3-Methyl-1-(pyrazine- 2-carboxamido)butylboronic acid
The compound is a drug product, analytical, and research material. The molecule has been synthesized and purified by the company's chemists. It is not an API impurity but an impurity standard for HPLC. This compound is a synthetic chemical that does not occur naturally in any living organism. It has been developed for use in drug development and research. The compound was custom synthesized by the company's chemists to meet customer demand for high purity standards of this compound. It is used as a pharmacopoeia standard for HPLC analysis and drug development.Purity:Min. 95%D-Phe(6)-Semaglutide
D-Phe(6)-Semaglutide is a semaglutide impurity. The amino acid at position 6 has been replaced by the D-form of the amino acid D-phenylalanine (D-Phe). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/molSemaglutide Impurity 51 (D-Thr 7)
D-Thr(7)-Semaglutide is a semaglutide impurity. The amino acid at position 7 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/molLinear Semaglutide
Linear semaglutide, or simply L-Sema, is the semaglutide compound without the lipid side chain modification. It is essentially a linear version of the peptide.Formula:C152H230N42O47Molecular weight:3,397.76 g/molD-Thr(5)-Semaglutide
D-Thr(5)-Semaglutide is a semaglutide impurity. The amino acid at position 5 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/molD-Asp(9)-Semaglutide
D-Asp(9)-Semaglutide is a semaglutide impurity. The amino acid at position 9 has been replaced by the D-form of the amino acid D-aspartic acid (D-Asp). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.
Formula:C187H291N45O59Molecular weight:4,113.64 g/molLisinopril EP Impurity E
CAS:Lisinopril EP Impurity E is an impurity of lisinopril, which is a prescription drug used to treat high blood pressure. This impurity was found in a preparative high performance liquid chromatography (HPLC) and mass spectroscopy analysis of the drug. The molecular weight of Lisinopril EP Impurity E was determined to be 317.2 amu, which corresponds to the molecular formula C7H13NO2. The FT-IR spectrum showed that this impurity has an ammonium group at 1859 cm-1 and butanoic acid at 1647 cm-1.Formula:C21H31N3O5Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:405.49 g/molLisinopril
CAS:Lisinopril, an ACE inhibitor, treats hypertension, heart failure, heart attacks, and prevents diabetes-related eye and kidney issues.Formula:C21H31N3O5Purity:97.59% - 99.34%Color and Shape:SolidMolecular weight:405.49(2,6-Dimethylphenoxy)acetic Acid
CAS:Controlled ProductFormula:C10H12O3Color and Shape:NeatMolecular weight:180.24-(Phenylamino)-1-benzyl-4-piperidinecarboxamide
CAS:Controlled ProductApplications Used as modulators of muscarinic receptors for treatment of CNS disorders.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Coghlan, M., et al.: J. Med. Chem., 44, 1627 (2001), Ashcroft, F., et al.: J. Clin. Invest., 115, 2047 (2005), Bryan, J., et al.: Curr. Pharm. Des., 11, 2699 (2005),Formula:C19H23N3OColor and Shape:NeatMolecular weight:309.41(S)-(-)-α-Methylbenzylamine
CAS:Controlled ProductApplications (S)-(-)-α-Methylbenzylamine (cas# 2627-86-3) is a compound useful in organic synthesis.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the packageFormula:C8H11NColor and Shape:NeatMolecular weight:121.18N2-(S)-1-Carboxy-3-phenylpropyl-L-lysine
CAS:Controlled ProductStability Hygroscopic
Applications Lisinopryl impurity.
References Goa, K.L., et al.: Drugs, 52, 564 (1996), Cao, X.J., et al.: J. Pharm. Biomed. Anal., 39, 39 (2005),Formula:C16H24N2O4Color and Shape:White To Light BeigeMolecular weight:308.37Semaglutide impurity
CAS:Lipid chain (stearic bi-acid) plus γ-glutamic acid or glutamate (γ-Glu) amino acid.Formula:C35H63N3O13Molecular weight:733.89 g/molLysipressin amide, acetate
CAS:Lysipressin amide, acetate is an analog of vasopressin, a powerful vasopressin used to regulate blood pressure. Endogenous vasopressin in most mammalian species.Formula:C48H68N12O15S2Purity:98%Color and Shape:SolidMolecular weight:1117.26CP5V
CAS:CP5V, a PROTAC, degrades Cdc20, halts mitosis, and inhibits cancer growth by targeting it for VHL-mediated ubiquitination and proteasome destruction.Formula:C46H66Cl3N9O12SPurity:98%Color and Shape:SolidMolecular weight:1075.499-(2,5-d|-Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin
CAS:Controlled ProductApplications 9-(2,5-d|Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin is a stereoisomer of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.
References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),Formula:C72H99N17O25Color and Shape:NeatMolecular weight:1602.66Boceprevir-d9
CAS:Controlled ProductApplications A labelled NS3 serine protease inhibitor of hepatitis C virus. It is a COVID19-related research product.
References Malcolm, B., et al.: Antimicrob. Agents Chemother., 50, 1013 (2006); Cubero, M., et al.: Virology, 370, 237 (2008); Venkatraman, S., et al.: J. Med. Chem., 49, 6074 (2006);Formula:C272H9H36N5O5Color and Shape:NeatMolecular weight:528.73Daptomycin Impurity B1-I
Applications Daptomycin Impurity B1-1 is an impurity of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.
References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),Formula:C44H66N10O15•(C2HF3O2)Color and Shape:Off White SolidMolecular weight:975.0511402(2S)-1-Nitrosopyrrolidine-2-carboxamide
CAS:Controlled ProductFormula:C5H9N3O2Color and Shape:NeatMolecular weight:143.14(S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS:Controlled ProductApplications (S,S)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);Formula:C19H24N4O4Color and Shape:NeatMolecular weight:372.42(alphaR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt
CAS:Controlled ProductApplications Bortezomib (B675700) intermediate. A boronic acid dipeptide derivative as proteasome inhibitors.
References Kisselev, A., et al.: Chem. Biol., 8, 739 (2001), Kisselev, A., et al.: J. Biol. Chem., 278, 35869 (2003), Verdoes, M., et al.: Chem. Biol., 13, 1217 (2006),Formula:C15H28BNO2·C2HF3O2Color and Shape:NeatMolecular weight:379.22Lysipressin Acetic Acid Salt
CAS:Applications Lysipressin Acetic Acid Salt, is an analog of Vasopressin (A769550), a powerful vasopressor used to modulate blood pressure. An endogenous antidiuretic hormone in most mammalian species. It is released into the blood from nerve terminals in the posterior pituitary and median eminence. It is a neurotransmitter in the central nervous system and also implicated in a variety of physiological processes such as regulating water balance by antidiuretic action.
References Yamashita, K. et al.: Mol. Phylo., 67, 520 (2013); Hua F. et al.: J. Emerg. Med., 44, 434 (2013); Perucca, J. et al.: J. AM. Soc. Nephrol., 19, 1721 (2008); Toba, K. et al.: Prog. Brain Res., 119, 337 (1998); Berrada, K. et al.: J. Biol. Chem., 275, 27229 (2000);Formula:C46H65N13O12S2·xC2H4O2Color and Shape:White SolidMolecular weight:1116.3Voclosporin M1 (IM1-Diol-1) metabolite
Formula:C63H113N11O14Purity:>85%Color and Shape:NeatMolecular weight:1248.66Lisinopril (8R,S)-Diketopiperazine (Mixture of Diastereomers)Mps1-IN-1 dihydrochloride
CAS:Controlled ProductStability Hygroscopic
Applications Lisinopril (L468985) impurity.
References Drummer, O., et al.: Arzneim.-Forsch. Drug Res., 38, 647 (1988), Simpson, K., et al.: Drugs, 59, 1149 (2000),Formula:C21H29N3O4Color and Shape:NeatMolecular weight:387.47Lopinavir Metabolite M-3/M-4
CAS:Controlled ProductApplications A major metabolite of Lopinavir (L469480) . It is a COVID19-related research product.
References Molla, A., et al.: J. Virology, 250, 255 (1998), Sham, H., et al.: Antimicrob. Agents Chemother., 42, 3218 (1998), Kumar, G., et al.: Drug Metab. Dispos., 27, 86 (1999),Formula:C37H48N4O6Color and Shape:NeatMolecular weight:644.8Linear Daptomycin Hydrochloride Salt
CAS:Applications Linear Daptomycin Hydrochloride Salt is the hydrochloride salt of L466470, which is the open-conformation of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial. Daptomycin Impurity
References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),Formula:C72H103N17O27·x(ClH)Purity:~80%Color and Shape:NeatMolecular weight:1675.1t-Butyl 4-Bromobutanoate
CAS:Controlled ProductApplications t-Butyl 4-bromobutanoate is a useful research chemical for organic synthesis and other chemical and pharmaceutical processes.
References Brudeli, B., et al.: Bioorg. Med. Chem., 18, 8600 (2010); Colak, S., et al.: Macromolecules, 41, 8436 (2008)Formula:C8H15BrO2Color and Shape:NeatMolecular weight:223.11(S)-N-[1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2yl]pyrazine-2-carboxamide
Controlled ProductFormula:C19H22N4O4Color and Shape:NeatMolecular weight:370.4(S)-Lisinopril-d5 Sodium
CAS:Controlled ProductFormula:C21H26D5N3NaO5Color and Shape:NeatMolecular weight:433.51(D-His2)-Leuprolide Trifluoroacetic Acid Salt
CAS:Controlled ProductImpurity Leuprolide Acetate EP Impurity B TFA salt
Applications Synthetic nonapeptide agonist analog of LH-RH. Antineoplastic (hormonal).
References Vilchez-Martinez, J.A., et al.: Biochem. Biophys. Res. Commun., 59, 1226 (1974), Sennello, L.T., et al.: J. Pharm. Sci., et al.: 75, 158 (1986), Wheeler, J.M., et al.: Am.J. Obstet. Gynecol., 167, 1367 (1992), Eri, L.M., et al.: J. Urol., 150, 359 (1993),Formula:C59H84N16O12·x(C2HF3O2)Color and Shape:NeatMolecular weight:1209.398N-[(1S)-2-[(3-Methylbutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide
CAS:Controlled ProductFormula:C19H24N4O2Color and Shape:White To Off-WhiteMolecular weight:340.4195Trofinetide (>90%)
CAS:Controlled ProductApplications Trofinetide is a synthetic analogue of the endogenous N-terminus tripeptide, Glycine-Proline-Glutamate (GPE), that has shown to be neuroprotective in animal models of brain injury.
References Wei, H.H. et al.: J Neuroinflammation. 2009 Aug 5;6:19.Formula:C13H21N3O6Purity:>90%Color and Shape:NeatMolecular weight:315.32(S)-4-Oxo-homophenylalanine Hydrochloride
CAS:Controlled ProductStability Hygroscopic
Applications (S)-4-Oxo-homophenylalanine Hydrochloride is a derivative of L-Homophenylalanine (H600500); an antitumor agent.
References Brunner, Henri., et al.: Eur. J. Med. Chem., 25, 35 (1990)Formula:C10H12ClNO3Color and Shape:NeatMolecular weight:229.66N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib
CAS:Controlled ProductApplications N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);Formula:C19H22N4O3Color and Shape:White To Off-WhiteMolecular weight:354.4031-Nitrosopyrrolidine-2-carboxylic Acid
CAS:Controlled ProductApplications 1-nitrosopyrrolidine-2-carboxylic acid (cas# 2571-28-0) is a useful research chemical.
Formula:C5H8N2O3Color and Shape:NeatMolecular weight:144.129Cyclosporin AM 4N
CAS:Controlled ProductFormula:C61H109N11O12Color and Shape:NeatMolecular weight:1188.58(AlphaS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-Alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
CAS:Controlled ProductImpurity Lopinavir EP Impurity R
Applications (αS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide (Lopinavir EP Impurity R) is an impurity of Lopinavir (L469480), a selective HIV protease inhibitor.
References Chitturi, S.R., et al.: J. Pharma. Biomed. Anal., 48, 1430 (2008); Devi, A.S.L., et al.: Magnet. Reson. Chem., 45, 424 (2007);Formula:C47H58N4O7Color and Shape:NeatMolecular weight:791.0(alphaS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride
CAS:Controlled ProductApplications (αS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride is a Bortezomib (B675700) intermediate which is used in the evaluation of bone-targeted proteasome inhibitors for myeloma.
References Agyin, J.K., et al.: Bioorg. Med. Chem. Lett., 23, 6455 (2013); Traenckner, E., et al.: EMBO. J., 13, 5433 (1994)Formula:C24H37BN2O3·ClHColor and Shape:NeatMolecular weight:448.83413,5,3',5'-Tetraiodo Thyroacetamide
CAS:Controlled ProductImpurity Levothyroxine Acetamide Impurity
Applications 3,5,3',5'-Tetraiodo Thyroacetamide is a thyroid hormone analogue, a Thyroxine (T425600) impurity.
References Andre, M., et al.: J. Chromatogr., 741, 146 (1996),Formula:C14H9I4NO3Color and Shape:Light Orange Colour To Light BrownMolecular weight:746.84N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers)
CAS:Controlled ProductApplications N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers) is an impurity of lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor.
References Shinde, V., et. al.: J. Pharm. Biomed. Anal., 43, 381 (2007); Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)Formula:C31H41N3O7Color and Shape:NeatMolecular weight:567.675-Oxo-L-proline-d5
CAS:Controlled ProductApplications 5-Oxo-L-proline-d5 is a labelled cyclized derivative of L-Glutamic Acid (G596960). The pyroglutamate core has potential application for synthesis of novel anti-bacterials.
References Mischo A. et al.: ChemBioChem., 13, 1421 (2012); Angelov P. et al.: Org. Biomol. Chem.: 10, 3472 (2012);Formula:C5D5H2NO3Color and Shape:White To Off-WhiteMolecular weight:134.14Deschloro-4’-chloro Clomiphene Hydrochloride
CAS:Controlled ProductApplications An impurity of Clomiphene (C587025).
Formula:C26H29Cl2NOColor and Shape:NeatMolecular weight:442.42Dodecyl Polyoxyethylene (23) Aldehyde
CAS:Controlled ProductApplications Polyoxyethylene (23) Lauric Acid is an intermediate in the synthesis of Bril L-23 Proline (LIFETC1), a polyethylene glycol derivative of Proline (P755995), an amino acid and precursor (with vitamin C) for collagen, the building block of the structure of tendons, ligaments, arteries, veins and muscles.
References Bondarenko, L.B., et al.: Int. J. Peptides., 2, 1687 (2012); Rimer, T., et al.: Biomacromolecules, 13, 2110 (2012);Formula:C14H28O2(C2H4O)nColor and Shape:NeatMolecular weight:272.42(S,S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS:Controlled ProductImpurity Bortezomib USP Impurity L
Stability Unstable in Methanol
Applications (R)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);Formula:C19H24N4O4Color and Shape:White To Off-WhiteMolecular weight:372.42(S)-Hydroxy Des(boric Acid) Bortezomib
CAS:Controlled ProductImpurity Bortezomib USP Impurity J
Applications (S)-Hydroxy Des(boric Acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl, C. et al.: Chem. and Eng. News, 87, 41 (2009)Formula:C19H24N4O3Color and Shape:NeatMolecular weight:356.42(S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid
CAS:Controlled ProductApplications (S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid is an intermediate for Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);Formula:C31H42N4O6Color and Shape:NeatMolecular weight:566.69(R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium Chloride
CAS:Controlled ProductStability Hygroscopic
Applications (R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium chloride is an important co-factor of mammalian mitochondrial energy metabolism. It is also a good active ingredient for dry-skin.
References Geier, David A., et al.: Neurochem. Res., 38(11), 2336-2341 (2013);Tanno, Osamu, et al.: Fragrance J., 33(8), 82-85 (2005);Formula:C7H16NO3·ClColor and Shape:White To Off-WhiteMolecular weight:197.663,5,3',5'-Tetraiodo Thyroaldehyde
CAS:Controlled ProductImpurity Levothyroxine EP Impurity I; T4-Aldehyde (USP)
Applications 3,5,3',5'-Tetraiodo Thyroaldehyde (Levothyroxine EP Impurity I; T4-Aldehyde (USP)) is a Thyroid hormone analogue and a Thyroxine (T425600) analogue.
References Horst, C., et al.: Biochem. J., 261, 945 (1989), Kvetny, J., et al.: Horm. Metab. Res., 24, 322 (1992), Yamauchi, K., et al.: J. Biol. Chem., 274, 8460 (1999), Davis, P., et al.: J. Endocrinol. Invest., 25, 377 (2002),Formula:C13H6I4O3Color and Shape:Light Beige To BrownMolecular weight:717.8[9-Glycine]desmopressin
9-Glycine Desmopressin is a drug product that has been custom synthesized for use in research and development. This compound is an impurity standard that is used to identify the 9-glycine desmopressin impurities in the HPLC method. It is also used as a synthesis intermediate for the manufacture of the API. The CAS number for this compound is [CAS NO.]. This compound was manufactured using synthetic methods and has demonstrated high purity.Purity:Min. 95%N1.9,N1.9-Dimethyldesmopressin
N1.9,N1.9-Dimethyldesmopressin is a synthetic analog of the natural hormone vasopressin. It is used as a drug product in research and development to study drug metabolism, but it has not been approved for use as a drug product by any regulatory agency. Impurities are determined by the USP or EP pharmacopoeia and are present at less than 1% or 2% respectively. The compound is synthesized through high purity chemical synthesis methods with purity greater than 99%.Purity:Min. 95%Lisinopril diketopipirazine
CAS:Lisinopril diketopipirazine is an analytical drug product. The CAS number for this product is 219677-82-4. This product requires a custom synthesis and impurity standard. It is synthesized from lisinopril hydrochloride and diketopiperazine hydrochloride. Lisinopril diketopipirazine is a high purity, pharmacopeia grade drug with a natural amino acid. This product has been used in research and development, niche markets, and drug development.Formula:C21H29N3O4Purity:90%MinColor and Shape:White To Off-White SolidMolecular weight:387.47 g/mol[4-L-Glutamic Acid]-desmopressin
4-L-Glutamic Acid]-desmopressin is an analytical standard that is used to calibrate HPLC systems. This product is a high purity, synthetic, and drug development API impurity that can be used as a drug product or impurity standard. It is also available as an HPLC standard, niche, and custom synthesis. 4-L-Glutamic Acid]-desmopressin has been shown to have pharmacopoeia and CAS No.Purity:Min. 95%(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione
CAS:(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione is a drug product that is an impurity standard for the API (Active Pharmaceutical Ingredient) 5α-tetrahydrospiro[benzofuran-1(3H),2'(3'H)]pyrido-[2,1'-cyclohexan]-6β,7β-(1'H)-dione. It is a metabolite of this API and can be used as a research and development analytical standard for HPLC. The CAS number for this compound is 72744-67-3. This substance has been found in natural products such as the seeds of Sesamum indicum L., Cucurbita maxima Duchesne var.Formula:C8H10N2O42S2Purity:Min. 95%Molecular weight:870.29 g/mol(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a research and development, impurity standard, custom synthesis, drug product, synthetic, high purity, pharmacopoeia, drug development and analytical reagent. CAS No. 162148-17-6Formula:C9H12N2O4SPurity:Min. 95%Molecular weight:244.27 g/molLevothyroxine EP impurity B
CAS:Please enquire for more information about Levothyroxine EP impurity B including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C15H11ClI3NO4Purity:Min. 95%Molecular weight:685.42 g/molLevothyroxine lactose adduct
Levothyroxine is a drug product that is used for the treatment of hypothyroidism. It is an analog of thyroxine, which is synthesized in the thyroid gland. Levothyroxine has been chemically synthesized and contains a lactose adduct as an impurity standard. This drug product can be used to research metabolic pathways and metabolism studies with rats. Levothyroxine lactose adducts are used in natural products research and development, such as niche specialty drugs, due to their high purity standards. The CAS number for Levothyroxine lactose adduct is 266-072-3.Formula:C27H31I4NO14Purity:85%MinMolecular weight:1,101.15 g/mol(1S,2S)-Bortezomib
CAS:(1S,2S)-Bortezomib (Bortezomib) is an enantiomer of Bortezomib.Formula:C19H25BN4O4Purity:99.6%Color and Shape:SolidMolecular weight:384.24Ref: TM-T10061
1mg60.00€2mg92.00€5mg160.00€1mL*10mM (DMSO)163.00€10mg269.00€25mg429.00€50mg583.00€100mg783.00€Cetrorelix Acetate
CAS:Cetrorelix Acetate is gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM.Formula:C70H92ClN17O14·xC2H4O2Purity:97.96%Color and Shape:SolidMolecular weight:1491.11Felypressin acetate
CAS:Felypressin acetate (PLV-2) is an agonist of vasopressin 1 and acts on all arginine vasopressin receptors 1AS.Formula:C48H69N13O13S2Purity:97.06%Color and Shape:SolidMolecular weight:1100.27L-803087
CAS:L-803087: potent sst4 receptor agonist, 0.7 nM Ki, 280x selectivity, boosts AMPA responses & seizures in mice.Formula:C25H29F2N5O3Purity:99.37%Color and Shape:SolidMolecular weight:485.53Ref: TM-T11800
1mg50.00€5mg112.00€1mL*10mM (DMSO)126.00€10mg175.00€25mg366.00€50mg585.00€100mg928.00€200mg1,234.00€(5aS,10aS)-Tetrahydrodipyrrolo[1,2-a:1',2'-d]pyrazine-3,5,8,10(2H,5aH)-tetraone
CAS:The objective of this project is to design a microcontroller-based system that can monitor and diagnose the level of damage in a composite material. The system will consist of an array of sensors, actuators, and microcontrollers that are connected by a wireless network. The sensors will measure the levels of damage at each point within the composite material. The actuators will provide feedback to the sensors, adjusting their frequency and amplitude based on the level of damage detected. Microcontrollers will be responsible for analyzing data from the sensors and diagnosing any faults in the system. A miniaturized dry skin patch could be used as an alternative to traditional wet skin tests for monitoring skin health.Formula:C10H10N2O4Purity:Min. 95%Molecular weight:222.2 g/molMEDICA16
CAS:MEDICA16: GPR40 agonist, GPR120 partial agonist, ATP-citrate lyase inhibitor, lowers TG, boosts insulin sensitivity in muscle.Formula:C20H38O4Purity:99.62% - 99.87%Color and Shape:White SolidMolecular weight:342.51Ref: TM-T22967
5mg60.00€1mL*10mM (DMSO)80.00€10mg92.00€25mg168.00€50mg289.00€100mg419.00€500mg874.00€D-Ile-23-semaglutide trifluoroacetate
D-Ile(23)-Semaglutide trifluoroacetate is a semaglutide impurity. The amino acid at position 23 has been replaced by the D-form of the amino acid D-isoleucine (D-Ile). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Purity:Min. 95%AZD-1656
CAS:AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2Formula:C24H26N6O5Purity:97.07% - 99.37%Color and Shape:SolidMolecular weight:478.5Duostatin 5
CAS:Duostatin 5 (Duo-5) is a sea hare toxin analog commonly used in the synthesis of ADC compounds.Formula:C40H69N9O6Purity:96.98%Color and Shape:SolidMolecular weight:772.03Ref: TM-T77841
1mg54.00€5mg114.00€1mL*10mM (DMSO)142.00€10mg167.00€25mg313.00€50mg528.00€100mg848.00€CG 428
CAS:CG 428 is a potent tropomyosin receptor Kinase (TRK) Degrader (uSMITETM) with a DC50 of 0.36 nM.Formula:C43H43FN10O6Purity:99.86%Color and Shape:SolidMolecular weight:814.86Ref: TM-T41224
1mg166.00€5mg400.00€1mL*10mM (DMSO)414.00€10mg590.00€25mg888.00€50mg1,243.00€100mg1,693.00€500mg3,402.00€STAT3 degrader-2
CAS:STAT3 Degrader-2 is a PROTAC-based compound that effectively reduces the total STAT3 protein levels, and is utilized in the research of cancer and variousFormula:C59H62N9O13PPurity:98%Color and Shape:SolidMolecular weight:1136.15LRK-4189
CAS:LRK-4189, Oral PIP4K2C PROTAC degrader (DC50 <500 nM), induces apoptosis, activates interferon pathway, for MSS colorectal cancer (CRC).Formula:C43H49F2N9O4Color and Shape:SolidMolecular weight:793.9Reldesemtiv
CAS:Reldesemtiv (CK-2127107) boosts exercise capacity, targeting fast muscle troponin, EC50 3.4 μM.Formula:C19H18F2N6OPurity:97.27%Color and Shape:SolidMolecular weight:384.38Pidotimod diketopiperazine-6-propanoic acid
CAS:Pidotimod is an impurity in the drug product, which is a synthetic diketopiperazine-6-propanoic acid. Pidotimod is an impurity standard that is used in the development of drugs and as a pharmacopoeia. It has been shown to be metabolized by human liver microsomes and human erythrocytes.Formula:C9H12N2O4SPurity:Min. 95%Molecular weight:244.27 g/molLGD-6972
CAS:LGD-6972 is an antagonist of glucagon receptor.Formula:C43H46N2O5SPurity:98.8% - 99.62%Color and Shape:SolidMolecular weight:702.9Ref: TM-T11845
1mg84.00€5mg177.00€10mg260.00€1mL*10mM (DMSO)268.00€25mg447.00€50mg655.00€100mg888.00€C004019
CAS:C004019 is a small molecule PROTAC capable of targeting tau for selective protein degradation from the cell, while recruiting tau and E3 ligase (Vhl) for
Formula:C49H70N12O9S2Purity:99.89%Color and Shape:SoildMolecular weight:1035.29XY028-140
CAS:XY028-140 is a selective CDK4/6 inhibitor and degrader, acting via PROTAC with ligands for Cereblon and CDK in cancer cells.Formula:C39H40N10O7Purity:98.59%Color and Shape:SolidMolecular weight:760.8AMG 837 calcium hydrate
CAS:AMG 837 calcium hydrate is a potent GPR40 agonist with an EC50 of 13 nM.Formula:C52H44CaF6O8Purity:98.07%Color and Shape:SolidMolecular weight:950.97(S)-dHTC1
CAS:(S)-dHTC1 is a molecular glue degrader specifically targeting the transcriptional coactivator ENL. It exhibits high affinity binding to E3 ligase only upon formation of the ENL:(S)-dHTC1 complex, with an IC50 of 93 nM. In MV4;11 cells, (S)-dHTC1 degrades ENL with a DC50 of 26 nM. This compound can be utilized for acute myeloid leukemia research.Formula:C33H40N8O6SColor and Shape:SolidMolecular weight:676.786Tabimorelin hemifumarate
CAS:orally active ghrelin receptor (GHS-R1a) agonistFormula:C32H40N403C4H404Purity:98%Color and Shape:SolidMolecular weight:586.72(2S,4S)-Sacubitril
CAS:(2S,4S)-Sacubitril (Sacubitril Impurity C) is a stereoisomer derived from Sacubitril which is a potent NEP inhibitor.Formula:C24H29NO5Purity:98%Color and Shape:SolidMolecular weight:411.49Marizomib
CAS:Marizomib is a novel irreversible brain-permeable proteasome inhibitor that inhibits CT-L, CT-T-laspase-like, and trypsin-like 20S proteasomes.Cost-effective and quality-assured.Formula:C15H20ClNO4Purity:98.03% - 99.41%Color and Shape:SolidMolecular weight:313.78Pateamine A
CAS:Pateamine A: marine-sourced macrolide from Mycale hentscheli; anticancer, antiviral, and translation inhibitor.Formula:C31H45N3O4SColor and Shape:SolidMolecular weight:555.77PIN1 ligand-2
CAS:PIN1ligand-2 (Intermediate M6) is a ligand designed for PROTAC target proteins (Ligands for Target Protein for s). It can be utilized in the synthesis of PROTACT(Rac)-P1D-34.Formula:C15H25ClN2O6SColor and Shape:SolidMolecular weight:396.887SSTR5 antagonist 6
CAS:SSTR5 antagonist 6, an orally active antagonist specific to the somatostatin receptor subtype 5 (SSTR5), exhibits an IC50 value of 24 nM. This compound is utilized in researching type 2 diabetes [1].Formula:C22H28ClN3O4Color and Shape:SolidMolecular weight:433.93FK-565
CAS:FK-565 is a ligand of nucleotide-binding oligomerization domain-1 (NOD1) that induces a mouse model of arteritis.Formula:C22H38N4O9Color and Shape:SolidMolecular weight:502.559SSTR4 agonist 5
CAS:SSTR4 agonist5 (Compound 5) is an orally active agonist of the somatostatin receptor 4 (SSTR4) with an EC50 of 0.228 nM. It demonstrates good stability in human/rat liver microsomes and can inhibit mechanical hyperalgesia in rat models.Formula:C20H26N4OMolecular weight:338.447L-796778 acetate
CAS:L-796778 acetate is a selective sst3 receptor agonist. In CHO-K1 cells expressing hsst3 receptors, it acts as a partial agonist that inhibits Forskolin-induced cAMP production, with an IC50 value of 18 nM. Additionally, L-796778 acetate exhibits anticonvulsant properties.Formula:C31H44N6O9Color and Shape:SolidMolecular weight:644.716SST1 receptor antagonist-1
CAS:SST1 receptor antagonist-1 (Compound 23) is a selective antagonist of the somatostatin receptor 1 (SST1), showing a pKd of 9.11 for rSST1 and 8.79 for hSST1. This compound is applicable in research related to retinal and endocrine dysfunction, cancer, and neuropsychiatric disorders.Formula:C29H31F2N3O2Color and Shape:SolidMolecular weight:491.57Cyclosporin H
CAS:Lactams, nesoiFormula:C62H111N11O12Color and Shape:White Off-White SolidMolecular weight:1201.84137[D-His]-Leuprolide (5-Oxo-L-prolyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:Lactams, nesoiFormula:C59H84N16O12Color and Shape:Off-White PowderMolecular weight:1208.64546[Lys(Ac)]5-Octreotide (D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFormula:C51H68N10O11S2Color and Shape:Off-White PowderMolecular weight:1060.45105[D-Ser]-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-D-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:Lactams, nesoiFormula:C59H84N16O12Color and Shape:Off-White PowderMolecular weight:1208.64546




